Clinical Trial Update: Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) [Phase 3]

View source ↗

Summary

Phase 3 trial update noting ongoing enrollment by invitation for Pentoxifylline and Tocopherol (PENTO) in medication-related osteonecrosis of the jaw.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Bisphosphonate-related Osteonecrosis of the Jaw
• Medication-related Osteonecrosis of the Jaw

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Tocopherol (Vitamin E)

Snippet

Sponsor: University of Washington | Conditions: Medication-related Osteonecrosis of the Jaw, Bisphosphonate-related Osteonecrosis of the Jaw | Phase 3 | Status: ENROLLING_BY_INVITATION